Jalali Rakesh, Budrukkar Ashwini, Sarin Rajiv, Sharma Dayananda S
Department of Radiation Oncology, 113 Tata Memorial Hospital, Parel, Mumbai, India.
Radiother Oncol. 2005 Jan;74(1):37-44. doi: 10.1016/j.radonc.2004.09.014.
To report local control and follow up outcome data of high precision conformal radiotherapy in childhood brain tumours.
Between December 1999 and December 2002, 26 children (17 boys and 9 girls, median age 11.5 years) with incompletely excised or recurrent benign and low-grade brain tumours [13 craniopharyngiomas, 11 low-grade gliomas (LGG) and 2 others] were treated with three-dimensional (3D) conformal radiotherapy (CRT) (12 patients) and stereotactic conformal radiotherapy (SCRT) (14 patients). Gross tumour volume (GTV) included neuro-imaging based visible tumour and/or resected tumour bed. Clinical target volume (CTV) consisted of GTV+ 5 mm margin and planning target volume (PTV) consisted of additional 5 mm margin for CRT and 2 mm for SCRT. Treatment was delivered with 3-9 conformal fixed fields to a median dose of 54 Gy/30 fractions.
The actuarial 2 and 3 year disease free and overall survival was 96 and 100%, respectively (median follow up: 25 months, range 12-47 months). Radiological follow up available in 25 patients revealed complete response in 1, partial regression in 10, stable disease in 13 and progression in 1 patient (within the CTV). One patient with craniopharyngioma on a routine imaging revealed a mild asymptomatic cyst enlargement, which resolved with conservative management. A patient with chiasmatic glioma developed cystic degeneration and hydrocephalus 9 months after SCRT requiring cyst drainage and placement of a ventriculoperitoneal shunt.
High-precision conformal techniques delivering irradiation to a computer generated target volume employing 7-10 mm 3D margins beyond the visible tumour and/or resected tumour bed appear to be safe in children with incompletely resected or recurrent benign and low-grade brain tumours, based on these data.
报告儿童脑肿瘤高精度适形放疗的局部控制及随访结果数据。
1999年12月至2002年12月期间,26例(17例男孩,9例女孩,中位年龄11.5岁)不完全切除或复发的良性及低级别脑肿瘤患儿[13例颅咽管瘤、11例低级别胶质瘤(LGG)及2例其他肿瘤]接受了三维(3D)适形放疗(CRT)(12例患者)和立体定向适形放疗(SCRT)(14例患者)。大体肿瘤体积(GTV)包括基于神经影像的可见肿瘤和/或切除的肿瘤床。临床靶体积(CTV)由GTV加5mm边界组成,计划靶体积(PTV)由CRT额外加5mm边界和SCRT额外加2mm边界组成。采用3至9个适形固定野进行治疗,中位剂量为54Gy/30次分割。
精算2年和3年无病生存率及总生存率分别为96%和100%(中位随访时间:25个月,范围12至47个月)。25例患者的影像学随访显示,1例完全缓解,10例部分消退,13例病情稳定,1例(在CTV内)进展。1例颅咽管瘤患者在常规影像学检查中显示轻度无症状囊肿增大,经保守治疗后消退。1例视交叉胶质瘤患者在SCRT后9个月出现囊性变和脑积水,需要进行囊肿引流和脑室腹腔分流术。
基于这些数据,对于不完全切除或复发的良性及低级别脑肿瘤患儿,采用高精度适形技术将照射范围扩大至可见肿瘤和/或切除的肿瘤床外7至10mm的计算机生成靶体积似乎是安全的。